ENTITY
Innovent Biologics Inc

Innovent Biologics Inc (1801 HK)

382
Analysis
Health CareChina
Innovent Biologics, Inc. operates as a biopharmaceutical company. The Company develops, manufactures, and distributes monoclonal antibody drug candidates for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and other diseases. Innovent Biologics serves customers in China.
more
Company Event19 Mar 2025 07:00 • Upcoming
Add To Calendar
Company Event29 Aug 2024 00:00 • Upcoming
Add To Calendar
Company Event20 Mar 2024 07:00 • Upcoming
Add To Calendar
Company Event23 Aug 2023 06:00 • Upcoming
Add To Calendar
Company Event28 Mar 2023 06:00 • Upcoming
Add To Calendar
x